Selected research
Industry Research
Psychobiotic Supplements Industry Research Report 2026
Market perspective
The global Psychobiotic Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Psychobiotic Supplements is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Psychobiotic Supplements is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Psychobiotic Supplements include Life Extension, Lifted Naturals, NEURAXPHARM, Uplift Food Pty Ltd., Nutrimmun GmbH, InnovixLabs, Optibac Probiotics, Seraphina Therapeutics and SFI Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Psychobiotic Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Psychobiotic Supplements Market by Company
Life Extension
Lifted Naturals
NEURAXPHARM
Uplift Food Pty Ltd.
Nutrimmun GmbH
InnovixLabs
Optibac Probiotics
Seraphina Therapeutics
SFI Health
Microbiome Labs
G1 NUTRITION
Psychobiotic Supplements Segment by Type
Capsules
Tablets
Other
Psychobiotic Supplements Segment by Application
Offline Sales
Online Sales
Psychobiotic Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psychobiotic Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Psychobiotic Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psychobiotic Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Psychobiotic Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Psychobiotic Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Psychobiotic Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Tablets
- Other
Applications
- Offline Sales
- Online Sales
Companies covered
- Life Extension
- Lifted Naturals
- NEURAXPHARM
- Uplift Food Pty Ltd.
- Nutrimmun GmbH
- InnovixLabs
- Optibac Probiotics
- Seraphina Therapeutics
- SFI Health
- Microbiome Labs
- G1 NUTRITION
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Psychobiotic Supplements Market Size (2021-2032)
- 2.2.2 Global Psychobiotic Supplements Sales (2021-2032)
- 2.2.3 Global Psychobiotic Supplements Market Average Price (2021-2032)
- 2.3 Psychobiotic Supplements by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsules
- 2.3.3 Tablets
- 2.3.4 Other
- 2.4 Psychobiotic Supplements by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Offline Sales
- 2.4.3 Online Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Psychobiotic Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Psychobiotic Supplements Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Psychobiotic Supplements Revenue of Manufacturers (2021-2026)
- 3.4 Global Psychobiotic Supplements Average Price by Manufacturers (2021-2026)
- 3.5 Global Psychobiotic Supplements Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Psychobiotic Supplements, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Psychobiotic Supplements, Product Type & Application
- 3.8 Global Manufacturers of Psychobiotic Supplements, Established Date
- 3.9 Global Psychobiotic Supplements Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Life Extension
- 4.1.1 Life Extension Company Information
- 4.1.2 Life Extension Business Overview
- 4.1.3 Life Extension Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Life Extension Psychobiotic Supplements Product Portfolio
- 4.1.5 Life Extension Recent Developments
- 4.2 Lifted Naturals
- 4.2.1 Lifted Naturals Company Information
- 4.2.2 Lifted Naturals Business Overview
- 4.2.3 Lifted Naturals Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lifted Naturals Psychobiotic Supplements Product Portfolio
- 4.2.5 Lifted Naturals Recent Developments
- 4.3 NEURAXPHARM
- 4.3.1 NEURAXPHARM Company Information
- 4.3.2 NEURAXPHARM Business Overview
- 4.3.3 NEURAXPHARM Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 NEURAXPHARM Psychobiotic Supplements Product Portfolio
- 4.3.5 NEURAXPHARM Recent Developments
- 4.4 Uplift Food Pty Ltd.
- 4.4.1 Uplift Food Pty Ltd. Company Information
- 4.4.2 Uplift Food Pty Ltd. Business Overview
- 4.4.3 Uplift Food Pty Ltd. Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Uplift Food Pty Ltd. Psychobiotic Supplements Product Portfolio
- 4.4.5 Uplift Food Pty Ltd. Recent Developments
- 4.5 Nutrimmun GmbH
- 4.5.1 Nutrimmun GmbH Company Information
- 4.5.2 Nutrimmun GmbH Business Overview
- 4.5.3 Nutrimmun GmbH Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nutrimmun GmbH Psychobiotic Supplements Product Portfolio
- 4.5.5 Nutrimmun GmbH Recent Developments
- 4.6 InnovixLabs
- 4.6.1 InnovixLabs Company Information
- 4.6.2 InnovixLabs Business Overview
- 4.6.3 InnovixLabs Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 InnovixLabs Psychobiotic Supplements Product Portfolio
- 4.6.5 InnovixLabs Recent Developments
- 4.7 Optibac Probiotics
- 4.7.1 Optibac Probiotics Company Information
- 4.7.2 Optibac Probiotics Business Overview
- 4.7.3 Optibac Probiotics Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Optibac Probiotics Psychobiotic Supplements Product Portfolio
- 4.7.5 Optibac Probiotics Recent Developments
- 4.8 Seraphina Therapeutics
- 4.8.1 Seraphina Therapeutics Company Information
- 4.8.2 Seraphina Therapeutics Business Overview
- 4.8.3 Seraphina Therapeutics Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Seraphina Therapeutics Psychobiotic Supplements Product Portfolio
- 4.8.5 Seraphina Therapeutics Recent Developments
- 4.9 SFI Health
- 4.9.1 SFI Health Company Information
- 4.9.2 SFI Health Business Overview
- 4.9.3 SFI Health Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SFI Health Psychobiotic Supplements Product Portfolio
- 4.9.5 SFI Health Recent Developments
- 4.10 Microbiome Labs
- 4.10.1 Microbiome Labs Company Information
- 4.10.2 Microbiome Labs Business Overview
- 4.10.3 Microbiome Labs Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Microbiome Labs Psychobiotic Supplements Product Portfolio
- 4.10.5 Microbiome Labs Recent Developments
- 4.11 G1 NUTRITION
- 4.11.1 G1 NUTRITION Company Information
- 4.11.2 G1 NUTRITION Business Overview
- 4.11.3 G1 NUTRITION Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 G1 NUTRITION Psychobiotic Supplements Product Portfolio
- 4.11.5 G1 NUTRITION Recent Developments
5 Global Psychobiotic Supplements Market Scenario by Region
- 5.1 Global Psychobiotic Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Psychobiotic Supplements Sales by Region: 2021-2032
- 5.2.1 Global Psychobiotic Supplements Sales by Region: 2021-2026
- 5.2.2 Global Psychobiotic Supplements Sales by Region: 2027-2032
- 5.3 Global Psychobiotic Supplements Revenue by Region: 2021-2032
- 5.3.1 Global Psychobiotic Supplements Revenue by Region: 2021-2026
- 5.3.2 Global Psychobiotic Supplements Revenue by Region: 2027-2032
- 5.4 North America Psychobiotic Supplements Market Facts & Figures by Country
- 5.4.1 North America Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Psychobiotic Supplements Sales by Country (2021-2032)
- 5.4.3 North America Psychobiotic Supplements Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Psychobiotic Supplements Market Facts & Figures by Country
- 5.5.1 Europe Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Psychobiotic Supplements Sales by Country (2021-2032)
- 5.5.3 Europe Psychobiotic Supplements Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Psychobiotic Supplements Market Facts & Figures by Country
- 5.6.1 Asia Pacific Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Psychobiotic Supplements Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Psychobiotic Supplements Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Psychobiotic Supplements Market Facts & Figures by Country
- 5.7.1 South America Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Psychobiotic Supplements Sales by Country (2021-2032)
- 5.7.3 South America Psychobiotic Supplements Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Psychobiotic Supplements Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Psychobiotic Supplements Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Psychobiotic Supplements Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Psychobiotic Supplements Sales by Type (2021-2032)
- 6.1.1 Global Psychobiotic Supplements Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Psychobiotic Supplements Sales Market Share by Type (2021-2032)
- 6.2 Global Psychobiotic Supplements Revenue by Type (2021-2032)
- 6.2.1 Global Psychobiotic Supplements Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Psychobiotic Supplements Revenue Market Share by Type (2021-2032)
- 6.3 Global Psychobiotic Supplements Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Psychobiotic Supplements Sales by Application (2021-2032)
- 7.1.1 Global Psychobiotic Supplements Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Psychobiotic Supplements Sales Market Share by Application (2021-2032)
- 7.2 Global Psychobiotic Supplements Revenue by Application (2021-2032)
- 7.2.1 Global Psychobiotic Supplements Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Psychobiotic Supplements Revenue Market Share by Application (2021-2032)
- 7.3 Global Psychobiotic Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Psychobiotic Supplements Value Chain Analysis
- 8.1.1 Psychobiotic Supplements Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Psychobiotic Supplements Production Mode & Process
- 8.2 Psychobiotic Supplements Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Psychobiotic Supplements Distributors
- 8.2.3 Psychobiotic Supplements Customers
9 Global Psychobiotic Supplements Analyzing Market Dynamics
- 9.1 Psychobiotic Supplements Industry Trends
- 9.2 Psychobiotic Supplements Industry Drivers
- 9.3 Psychobiotic Supplements Industry Opportunities and Challenges
- 9.4 Psychobiotic Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst